Oncotelic Therapeutics Inc (OTLC)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

29397 AGOURA RD. AGUORA HILLS, CA 91301

Oxigene Inc engages in the research and development of products for use in the treatment of cancer and certain ocular diseases. The company's efforts in oncology are focused on developing products for application as direct cancer treatment agents, particularly vascular targeting agents.

Data as of 2021-07-19 08:27:53 -0400
Market Cap65.511 Million Shares Outstanding369.078 Million Avg 30-day Volume264.339 Thousand
P/E Ratio-8.56604 Dividend Yield EPS-0.085
Price/Sales46.79 Debt to Equity2.41 EBITDA-6.685 Million
Price to Book Value6.58 Forward PE Enterprise Value69.954 Million
Total Cash830.719 Thousand Current Debt13.027 Million Gross Profit1.4 Million
BETA 52-week High/Low0.38 / 0.16 Next Earnings Date2021-08-12 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from OTLC instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 0 0 (0.0%) 0 (0.0%)
Funds Holding: 1 1 0.0% (0.0%) (0.0%)
13F shares: 62.837 Thousand 62.599 Thousand 0.38%
% Ownership 0.0696 0.0699 -0.43%
New Positions:
Increased Positions 1 1 0.0%
Closed Positions
Reduced Positions
Total Calls
Total Puts
PUT/CALL Ratio
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding OTLC (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding OTLC BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

DIAMOND DAVID

  • Director
451,467 2021-07-08 1

SHAH AMIT B. CHIEF FINANCIAL OFFICER

  • Officer
1,057,093 2021-07-08 2

TRIEU VUONG CHAIRMAN AND CEO

  • Officer
  • Director
  • 10% Owner
204,962,210 2021-03-31 2

MAIDA ANTHONY E III CHIEF CLINICAL OFFICER

  • Officer
  • Director
1,537,314 2021-03-31 1

KING STEVEN W

  • Director
3,688,059 2021-03-31 1

SAUND SARAN CHIEF BUSINESS OFFICER

  • Officer
33,028,720 2021-03-31 1

PARK CHULHO CHIEF TECHNOLOGY OFFICER

  • Officer
2,833,992 2020-11-19 1

HWANG LARN

  • 10% Owner
4,095,581 2019-04-22 0

UCKUN FATIH CHIEF MEDICAL OFFICER

  • Officer
  • 10% Owner
1,492,742 2019-04-22 0

HSIAO CHAO

  • 10% Owner
2,987,076 2019-04-22 0

SCHWIETERMAN WILLIAM D PRESIDENT AND CEO

  • Officer
  • Director
0 2018-06-20 0

CHAPLIN DAVID

  • Director
0 2018-06-20 0

LOAR MATTHEW M CHIEF FINANCIAL OFFICER

  • Officer
0 2018-06-20 0

PEDDER SIMON

  • Director
0 2018-06-20 0

REYNOLDS DONALD ROGERS

  • Director
0 2018-06-20 0

SANDAGE BOBBY W. JR., PHD.

  • Director
0 2018-06-20 0

MCMAHON GERALD PHD

  • Director
0 2016-06-01 0

DRISCOLL FREDERICK W

  • Director
0 2016-06-01 0

HA PAMELA CONTROLLER

  • Officer
0 2015-06-04 0

HOWSON TAMAR D

  • Director
0 2015-05-28 0

RICHING BARBARA CHIEF FINANCIAL OFFICER

  • Officer
0 2015-05-28 0

LANGECKER PETER CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
77,993 2013-08-08 0

WOOD ALASTAIR JJ

  • Director
0 2013-07-01 0

JOHNSON DAVID LOUIS CHIEF FINANCIAL OFFICER

  • Officer
0 2012-04-02 0

KESSEL MARK

  • Director
No longer subject to file 2011-10-31 0

SHIEBLER WILLIAM N

  • Director
No longer subject to file 2011-10-31 0

FICKLING ROY H

  • Director
202,846 2011-01-02 0

MURPHY JAMES B CHIEF FINANCIAL OFFICER

  • Officer
0 2010-09-15 0

LAFFER ARTHUR B

  • Director
409,232 2009-12-31 0

SYMPHONY CAPITAL PARTNERS LP

SYMPHONY CAPITAL GP, L.P.

SYMPHONY GP, LLC

SYMPHONY VIDA HOLDINGS LLC

TARANTO HARRI V

  • Director
  • 10% Owner
  • SEE FOOTNOTE 2 AND REMARKSSEE FOOTNOTE 2 AND REMARKSSEE FOOTNOTE 2 AND REMARKSSEE FOOTNOTE 2 AND REMARKSSEE FOOTNOTE 2 AND REMARKS
27,117,118 2009-07-20 0

KOLLINS JOHN A CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2009-01-20 0

WALICKE PATRICIA A. VP AND CHIEF MEDICAL OFFICER

  • Officer
0 2009-01-20 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

KING STEVEN W - Director

2021-07-16 17:37:41 -0400 2021-07-08 A 357,412 a 357,412 direct

TRIEU VUONG - Director - Officer - > 10% Owner CHAIRMAN AND CEO

2021-07-16 17:38:27 -0400 2021-07-08 A 513,953 a 513,953 direct

SAUND SARAN - Officer CHIEF BUSINESS OFFICER

2021-07-16 17:35:47 -0400 2021-07-08 A 216,279 a 216,279 direct

SHAH AMIT B. - Officer CHIEF FINANCIAL OFFICER

2021-07-16 17:37:37 -0400 2021-07-08 A 698,256 a 698,256 direct

TRIEU VUONG - Director - Officer - > 10% Owner CHAIRMAN AND CEO

2021-07-16 17:38:27 -0400 2021-07-08 A 259,302 a 90,527,323 direct

SAUND SARAN - Officer CHIEF BUSINESS OFFICER

2021-07-16 17:35:47 -0400 2021-07-08 A 102,519 a 16,457,480 direct

SHAH AMIT B. - Officer CHIEF FINANCIAL OFFICER

2021-07-16 17:37:37 -0400 2021-07-08 A 298,837 a 358,837 direct

MAIDA ANTHONY E III - Director - Officer CHIEF CLINICAL OFFICER

2021-07-16 17:39:03 -0400 2021-07-08 A 400,000 a 400,000 direct

DIAMOND DAVID - Director

2021-07-16 17:36:50 -0400 2021-07-08 A 451,467 a 451,467 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
ONCOTELIC THERAPEUTICS INC OTLC 2021-07-23 22:15:03 UTC -6.7165 6.7965 1300000
ONCOTELIC THERAPEUTICS INC OTLC 2021-07-23 21:45:03 UTC -6.7165 6.7965 1300000
ONCOTELIC THERAPEUTICS INC OTLC 2021-07-23 21:15:03 UTC -6.7165 6.7965 1300000
ONCOTELIC THERAPEUTICS INC OTLC 2021-07-23 20:45:03 UTC -6.7165 6.7965 1300000
ONCOTELIC THERAPEUTICS INC OTLC 2021-07-23 20:15:05 UTC -6.7165 6.7965 1300000
ONCOTELIC THERAPEUTICS INC OTLC 2021-07-23 19:45:03 UTC -6.7165 6.7965 1300000
ONCOTELIC THERAPEUTICS INC OTLC 2021-07-23 19:15:03 UTC -6.7165 6.7965 1300000
ONCOTELIC THERAPEUTICS INC OTLC 2021-07-23 18:45:03 UTC -6.7165 6.7965 1300000
ONCOTELIC THERAPEUTICS INC OTLC 2021-07-23 18:15:03 UTC -6.7165 6.7965 1300000
ONCOTELIC THERAPEUTICS INC OTLC 2021-07-23 17:45:03 UTC -6.7165 6.7965 1300000
ONCOTELIC THERAPEUTICS INC OTLC 2021-07-23 17:15:02 UTC -6.7165 6.7965 1300000
ONCOTELIC THERAPEUTICS INC OTLC 2021-07-23 16:45:02 UTC -6.7165 6.7965 1300000
ONCOTELIC THERAPEUTICS INC OTLC 2021-07-23 16:15:03 UTC -6.7165 6.7965 1300000
ONCOTELIC THERAPEUTICS INC OTLC 2021-07-23 15:45:02 UTC -6.7165 6.7965 1300000
ONCOTELIC THERAPEUTICS INC OTLC 2021-07-23 15:15:03 UTC -6.7165 6.7965 1300000
ONCOTELIC THERAPEUTICS INC OTLC 2021-07-23 14:45:03 UTC -6.7165 6.7965 1300000
ONCOTELIC THERAPEUTICS INC OTLC 2021-07-23 14:15:03 UTC -6.7165 6.7965 1300000
ONCOTELIC THERAPEUTICS INC OTLC 2021-07-23 13:45:03 UTC -6.7165 6.7965 1300000
ONCOTELIC THERAPEUTICS INC OTLC 2021-07-23 13:15:03 UTC -6.7165 6.7965 1300000
ONCOTELIC THERAPEUTICS INC OTLC 2021-07-23 12:45:03 UTC -6.7165 6.7965 1300000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments